Binding of platelet factor 4 to heparin oligosaccharides
- 1 February 1983
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 209 (2) , 455-460
- https://doi.org/10.1042/bj2090455
Abstract
Heparin fractions of differing Mr (7800-18 800) prepared from commercial heparin by gel filtration and affinity chromatography on immobilized anti-thrombin III had specific activities when determined by anti-Factor Xa and anti-thrombin assays that ranged from 228 to 448 units/mg. The anti-Factor Xa activity of these fractions could be readily and totally neutralized by increasing concentrations of platelet factor 4 (PF4). That these fractions bound to immobilized PF4 was indicated by the complete binding under near physiological conditions of 3H-labelled unfractionated commercial heparin. An anti-thrombin III-binding oligosaccharide preparation (containing predominantly eight to ten saccharide units), prepared by degradation of heparin with HNO2 had high (800 units/mg) anti-Factor Xa, but negligible anti-thrombin, specific activity. The anti-Factor Xa activity of this material could not be readily neutralized by PF4, and the 3H-labelled oligosaccharides did not completely bind to immobilized PF4. A heterogeneous anti-thrombin III-binding preparation containing upwards of 16 saccharides had anti-thrombin specific activity of just less than one-half the anti-Factor Xa specific activity. This material was completely bound to immobilized PF4 and was eluted with similar concentrations of NaCl to those that were required to elute unfractionated heparins from these columns. Furthermore, increasing concentrations of PF4 neutralized the anti-Factor Xa activity of this material in a manner similar to that of unfractionated heparin. It is concluded that heparin oligosaccharides require saccharide units in addition to the anti-thrombin III-binding sequence in order to fully interact with PF4.This publication has 31 references indexed in Scilit:
- The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymersBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- The molecular size of the antithrombin‐binding sequence in heparinFEBS Letters, 1980
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin IIIBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin moleculeFEBS Letters, 1979
- The heparin-thrombin complex in the mechanism of thrombin inactivation by heparinBiochemical and Biophysical Research Communications, 1977
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976